LITHIUM-INDUCED DOWN-REGULATION OF AQUAPORIN-2 WATER CHANNEL EXPRESSION IN RAT-KIDNEY MEDULLA

被引:350
作者
MARPLES, D
CHRISTENSEN, S
CHRISTENSEN, EI
OTTOSEN, PD
NIELSEN, S
机构
[1] AARHUS UNIV,INST ANAT,DEPT CELL BIOL,DK-8000 AARHUS,DENMARK
[2] UNIV COPENHAGEN,DEPT PHARMACOL,DK-2200 COPENHAGEN,DENMARK
[3] RANDERS CENT HOSP,INST PATHOL,DK-8900 RANDERS,DENMARK
关键词
VASOPRESSIN; NEPHROGENIC DIABETES INSIPIDUS; COLLECTING DUCT; MEMBRANE TRAFFICKING; WATER BALANCE;
D O I
10.1172/JCI117863
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lithium, a widely used treatment for bipolar affective disorders, often causes nephrogenic diabetes insipidus, The effect of chronic lithium therapy on the expression of the vasopressin-regulated water channel Aquaporin-2 (AQP2) in rat kidney was examined, Membranes were prepared from inner medulla of one kidney from each rat, while the contralateral one was fixed for immunofluorescence and immunoelectronmicroscopy, Immunoblotting revealed that lithium treatment reduced AQP2 expression dramatically, to 31+/-8% after 10 d and to 4+/-1% after 25 d, coincident with development of severe polyuria, Immunofluorescence and immunogold quantitation confirmed the lithium-induced decrease in AQP2 expression (from 11.2+/-1.0 to 1.1+/-0.2 particles/mu m(2)). The downregulation was only partly reversed by return to lithium-free diet for 1 wk (40+/-8% of control), Furthermore, immunoblotting and immunogold quantitation revealed that 2 d of thirsting or 7 d of dDAVP treatment, in the continued presence of lithium, increased AQP2 expression by six- and threefold, respectively, coincident with increased urinary osmolality, Thirsting increased AQP2 immunolabeling mainly of vesicles, whereas dDAVP caused accumulation of AQP2 predominantly in the subapical region and plasma membrane, Thus, lithium causes marked downregulation of AQP2 expression, only partially reversed by cessation of therapy, thirsting or dDGVP treatment, consistent with clinical observations of slow recovery from lithium-induced urinary concentrating defects.
引用
收藏
页码:1838 / 1845
页数:8
相关论文
共 29 条
[1]  
AGRE P, 1993, AM J PHYSIOL, V265, pF463
[2]  
BALDESSARINI RJ, 1992, PHARMACOL BASIS THER, P383
[3]   PREVALENCE, PATHOGENESIS, AND TREATMENT OF RENAL DYSFUNCTION ASSOCIATED WITH CHRONIC LITHIUM-THERAPY [J].
BOTON, R ;
GAVIRIA, M ;
BATLLE, DC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 10 (05) :329-345
[4]  
CHOU CL, 1994, J AM SOC NEPHROL, V5, pA268
[5]  
CHRISTENSEN S, 1976, ACTA PHARMACOL TOX, V38, P241
[6]   EFFECTS OF LITHIUM ON CIRCADIAN CYCLES IN FOOD AND WATER-INTAKE, URINARY CONCENTRATION AND BODY-WEIGHT IN RATS [J].
CHRISTENSEN, S ;
AGNER, T .
PHYSIOLOGY & BEHAVIOR, 1982, 28 (04) :635-640
[7]   PATHOGENESIS OF NEPHROGENIC DIABETES-INSIPIDUS DUE TO CHRONIC ADMINISTRATION OF LITHIUM IN RATS [J].
CHRISTENSEN, S ;
KUSANO, E ;
YUSUFI, ANK ;
MURAYAMA, N ;
DOUSA, TP .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (06) :1869-1879
[8]  
CHRISTENSEN S, 1982, RENAL PHYSIOL BIOCH, V5, P95
[10]  
CRHISTENSEN S, 1988, LITHIUM THERAPY MONO, V2, P20